Gabon vs Guinea: Death rate from Parkinson's disease
Gabon
1.72 deaths per 100,000 people
in 2021
Guinea
1.71 deaths per 100,000 people
in 2021
Gabon rank
125th
Guinea rank
126th
Death rate from Parkinson's disease over time
- Gabon
- Guinea
How they compare
Gabon currently reports 1.72 deaths per 100,000 people against 1.71 deaths per 100,000 people in Guinea, a difference of 0.01 deaths per 100,000 people.
Across all 22 years both countries report, Gabon has been ahead every year.
Gabon ranks 125th and Guinea ranks 126th of 194 countries.
Gabon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Gabon | Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.48 deaths per 100,000 people | 1.73 deaths per 100,000 people | 0.751 deaths per 100,000 people | Gabon |
| 2010s | 2.34 deaths per 100,000 people | 1.8 deaths per 100,000 people | 0.542 deaths per 100,000 people | Gabon |
| 2020s | 1.8 deaths per 100,000 people | 1.76 deaths per 100,000 people | 0.04 deaths per 100,000 people | Gabon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from parkinson's disease, Gabon or Guinea?
- Gabon, at 1.72 deaths per 100,000 people against 1.71 deaths per 100,000 people in Guinea as of 2021.
- What is the difference in death rate from parkinson's disease between Gabon and Guinea?
- 0.01 deaths per 100,000 people, with Gabon ahead.
- How many years of comparable data are there for Gabon and Guinea?
- 22 years are reported by both, from 2000 to 2021.
- How do Gabon and Guinea rank globally for death rate from parkinson's disease?
- Gabon ranks 125th and Guinea ranks 126th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Death rate from Parkinson's disease. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from parkinson disease in both sexes, per 100,000 people.